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Isoeugenol is an essential oil constituent of nutmeg, clove, and cinnamon. Despite
isoeugenol’s promising antimicrobial activity, no studies have yet investigated its
mode of antibacterial action at the molecular level. The aim of this study is to clarify
isoeugenol’s antibacterial mode of action using the Gram-negative and Gram-positive
model organisms Escherichia coli and Listeria innocua, respectively. We determined the
antimicrobial activity of isoeugenol against the model organisms, and examined how
isoeugenol affects cell morphology, cell membrane permeabilization, and how isoeugenol
interacts with phospholipid membranes using vesicle and supported lipid bilayer models.
Isoeugenol demonstrated a bactericidal activity against E. coli and L. innocua that
did not affect cell morphology, although the cell membrane was permeabilized. We
hypothesized that the cell membrane was the primary site of action, and studied this
interaction in further detail using purified membrane model systems. Isoeugenol’s
permeabilization of calcein-encapsulated vesicles was concentration dependent, and
isoeugenol’s interaction with giant unilamellar vesicles indicated increased membrane
fluidity and a non-disruptive permeabilization mechanism. This contradicted membrane
fluidity measurements on supported lipid bilayers (SLBs), which indicated decreased
membrane fluidity. However, further investigations demonstrated that the interaction
between isoeugenol and bilayers was reversible, and caused membranes to display
heterogeneous topography, an increased mass, and a higher degree of hydration. In
conclusion, we propose that isoeugenol interacts with membranes in a reversible
non-disruptive detergent-like manner, which causes membrane destabilization.
Furthermore, we argue that isoeugenol increasesmembrane fluidity. Our work contributes
to the understanding of how essential oil constituents interact with cell components.
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Introduction
Essential oils from plants, herbs, or spices constitute a broad range of low molecular weight
organic compounds. These constituents can be categorized into four groups based on their
chemical structure: terpenes, terpenoids, phenylpropenes, and a group containing other metabolic
degradation products from plants (Hyldgaard et al., 2012a). These oils and their individual
constituents have received attention as a natural resource of food additives that can function
as aromatic flavorings, antioxidants, and antimicrobials (Rajakumar and Rao, 1993; Brenes and
Roura, 2010; Hyldgaard et al., 2012a).
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Isoeugenol belongs to the group of phenylpropenes and
occurs naturally in nutmeg, cinnamon, and clove. Interestingly,
isoeugenol has proven antimicrobial activity comparable to,
and even exceeding, its highly antimicrobial isoform eugenol
(Zemek et al., 1979, 1987; Janssens et al., 1990; Laekeman
et al., 1990; Dal Pozzo et al., 2012). A general ranking of
the antimicrobial activity of essential oil constituents placed
eugenol as having higher activity than e.g., carvacrol, cinnamic
acid, and cinnamaldehyde (Burt, 2004). The antibacterial activity
of isoeugenol has been proposed to be due to its free
hydroxyl group and its position of double bonds in α, β
positions of the side chain, and a methyl group in the γ
position (Figure 1) (Zemek et al., 1979; Laekeman et al., 1990).
Isoeugenol’s antibacterial activity covers a broad range of Gram-
positive and Gram-negative bacteria, including Escherichia
coli, Bacillus licheniformis, Micrococcus luteus, Pseudomonas
aeruginosa, Salmonella type B, and Staphylococcus aureus (Zemek
et al., 1979, 1987; Laekeman et al., 1990).
In recent years there has been a growing interest in
investigating antimicrobial compounds regarding their
respective modes of action and categorize these in order to
systematize their fields, understand resistance and tolerance
mechanisms of microorganisms to antimicrobials, or find
alternative treatment options (Yeaman and Yount, 2003;
Desbois and Smith, 2010; Hyldgaard et al., 2012a). In spite of
isoeugenol’s promising antibacterial activity, no studies have
yet been performed to identify how isoeugenol affects bacteria
at the molecular scale. One study evaluated isoeugenol’s mode
of antifungal action against Candida spp., and suggested that
isoeugenol inhibits H+-ATPase, which triggers intracellular
acidification and cell membrane breakages (Bhatia et al., 2012).
Focusing on the mode of action of the structurally closely related
compound eugenol, studies indicate that the cell structure
becomes distorted due to a non-specific cytoplasmic membrane
permeabilization effect together with the ability of eugenol to
inhibit enzyme or protein functionality (Thoroski et al., 1989;
Wendakoon and Morihiko, 1995; Gill and Holley, 2006b,a;
Hemaiswarya and Doble, 2009). Based on these mode of
action studies on the related eugenol molecule and isoeugenol’s
structure, we hypothesize that the hydrophobic isoeugenol
inserts into the polar head group region of lipid bilayers where
it cause alterations and damages to the cell membrane, which
FIGURE 1 | Chemical structures of essential oil components.
could enhance uptake of isoeugenol, leading to effects on
protein/enzyme function.
In the present study we aim to investigate isoeugenol’s
antibacterial mechanism of action using the model organisms
E. coli and L. innocua together with a broad range of model
membrane systems to evaluate isoeugenol’s action on cell
viability, cellular morphology, enzyme activity, and membrane
integrity, fluidity, and hydration.
Materials and Methods
Materials
Food grade isoeugenol >99% pure was purchased from
Sigma-Aldrich Chemie (St. Louis, MO, USA). Isoeugenol
was mixed with 1% polysorbate 80 (Merck, Hohenbrunn,
Germany) prior to being diluted in either 5mM MES (2-
(N-morpholino)ethanesulfonic acid, Sigma-Aldrich Chemie,
Steinheim, Germany), 30 g/L tryptic soy broth (TSB, Merck,
Darmstadt, Germany), or TSB with 1.5% agar (TSA, Merck,
Darmstadt, Germany), all at pH 6.0. Stains used in this
study involve calcein disodium salt obtained from Fluka
(Buchs, Switzerland) and fluorescein diacetate (FDA) acquired
from Merck (Calbiochem, Darmstadt, Germany), 1,6-diphenyl-
1,3,5-hexatriene (DPH) bought from Sigma-Aldrich (D208000,
St. Louis, MO, USA), and propidium iodide (PI, L7012,
L13152), Alexa Fluor 633 hydrazide (A30634), and dextran
labeled with Alexa Fluor 488 (D22910) from Molecular
Probes (Oregon, USA). We acquired 1,2-dioleoyl-sn-glycero-
3-phospho-(1′-rac-glycerol) (DOPG, 840475P), 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC, 850375P), and E. coli polar
lipid extract [100600C, 67% phosphatidylethanolamine (PE);
23.2% phosphatidylglycerol (PG); 9.8% cardiolipin (CL)] from
Avanti Polar Lipids, Inc. (Alabaster, USA). Triton™ X-100
solution was bought from Sigma (St. Louis, MO).
Bacterial Growth Conditions
Escherichia coli K12 (LZB035, Blades Biological Ltd., Cowden,
UK) and L. innocua (DSM 20649, DSMZ, Braunschweig,
Germany) were cultured in TSB or TSA at 25◦C until having
an optical density at 620 nm (OD620) between 0.05 and 0.25,
representing the exponential growth phase. We harvested
cells by centrifugation (5000 × g, 10min), discarded the
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supernatant, resuspended the pellet in sterile MES-buffer, TSB,
or Ringer’s solution (Merck, Darmstadt, Germany), ensured that
the OD620 was between 0.05 and 0.25 using a photospectrometer
(Spectrostar Nano, BMG Labtech, Ortenberg, Germany), and
diluted the cell cultures with the appropriate solution to cell
densities of 106 or 107 CFU/mL.
Minimum Inhibition Concentration Determination
Using a Broth Microdilution Assay
Minimum inhibition concentration values were determined
using absorbance measurements of serial dilutions of isoeugenol
into TSB in concentrations ranging from 0 to 0.6mg/mL and 0
to 1.5mg/mL with or without 5 × 105 CFU/mL of E. coli and
L. innocua, respectively. Triplicate cell cultures were prepared in
MES-buffer with final cell densities of 107 CFU/mL. Microtiter
plates (No. 260887, NUNC plates, Thermo Scientific) with 96-
wells were prepared by adding 100µL TSB in all wells, then
adding isoeugenol in a 1.5-serial dilution series to a final
concentration ranging either between 0 to 1.2 or 0 to 3mg/mL.
Then 90µL TSB and 10µL cell culture were added. Cell-
free controls with isoeugenol, and isoeugenol-free controls with
cells were prepared in triplicates. The OD620 was monitored
sequentially every 20min, for 24 h at 25◦C using a plate reader
(Sunrise, Tecan, Männedorf, Switzerland). The OD620 from cell-
free wells containing isoeugenol concentrations were subtracted
from sample wells in order to remove background absorbance
from isoeugenol. The MIC value was defined as the first
concentration resulting in an average increase of OD620 ≤ 5% of
the growth controls OD620 values.
Isoeugenol’s Time-kill Activity
Detection of MIC values of isoeugenol only identified growth
inhibition, but left out information about isoeugenol’s effect on
cell viability, and if it acted bactericidal or bacteriostatic. We
investigated time dependent viability changes using a modified
Miles and Misra method (Miles et al., 1938) to evaluate E. coli
and L. innocua susceptibility to isoeugenol while suspended in
TSB. Briefly, triplicate cell suspensions with 107 CFU/mL were
prepared in Ringer’s solution. Cell suspensions were mixed with
TSB amended with isoeugenol in 50mL Falcon tubes reaching
final cell densities of 5 × 105 CFU/mL and final isoeugenol
concentrations of 0, ½× MIC, MIC, and 2× MIC in triplicate.
Samples were vortexed prior to serial dilution to 10−6 in Ringer’s
solution at time-points 0, 1, 4, 8, 12, 16, 20, and 24 h of incubation
at 25◦C. Twenty microliters aliquots from each serial dilution
step were transferred to two TSA plates in numbered sections,
and incubated at 25◦C for 24 h. Colony forming units were
counted after incubation.
Atomic Force Microscopy Imaging of Whole Cells
Treated with Isoeugenol
We used atomic force microscopy (AFM) to investigate if
isoeugenol caused changes in cell morphology. Coverslips coated
with adhesive mussel proteins (Cell-TAK™, Cell and Tissue
adhesive, Becton Dickinson Biosciences, Temse, Belgium) were
used to firmly immobilize bacterial cells so they could withstand
the lateral forces inflicted by the cantilever during AFM imaging
(Meyer et al., 2010). Briefly, coverslips were cleaned in 70%
ethanol for 10min, rinsed with MilliQ water, and air-dried in
upright position. Then a 1 × 1 cm square was drawn with a
hydrophobic marker (Pap pen, G. Kisker, Steinfurt, Germany)
on each coverslip. Adhesive protein solution (28.5µL freshly
made 0.1M NaHCO3, 0.5µL 1M NaOH, and 1µL Cell-TAK™)
was added to the hydrophobic square on each coverslip, air-
dried 20min at room temperature. Finally, excessive proteins
were removed by submerging coverslips in MilliQ water. The
coverslips were air-dried, and stored for a maximum of 2 weeks
at 4◦C.
We mixed cell suspensions and isoeugenol stock solutions
to have final concentrations of 5 × 105 CFU/mL and 0, ½×
MIC, MIC, or 2× MIC, respectively. Samples were incubated
60min at 25◦C, followed by three washing steps of harvesting
(5000 × g, 10min) and resuspending the pellet in MES-buffer.
We immobilized cells to the substrate by applying 100µL cell
suspension to the Cell-TAK™ coating, and let the cells settle for
15min at room temperature before removing non-adhered cells
by rinsing with MES-buffer. Coverslips with adhered cells were
air-dried and placed in the JPK sample holder (JPK Instruments,
Berlin, Germany) prior to imaging with a JPK NanoWizard R©
II AFM (JPK Instruments, Berlin, Germany) using intermittent
contact mode. Freshly UV-irradiated Si3N4 cantilevers from
Olympus (OMCL-AC160TS, Manheim, Germany) with an apical
radius less than 10 nm, a resonance frequency of 300 kHz, and
a nominal spring constant of 42 N/m were used for imaging.
At least three AFM images of E. coli and L. innocua cells were
acquired for each of the triplicate samples at 512 pixels per line at
a scan rate of 0.5Hz of 4 × 4 and 3 × 3µm areas, respectively.
Images were processed in the JPK Data Processing software
(Version 4.2.50) by subtracting a first order polynomial from each
scan lines, and we manually selected areas to exclude from the
fit if they contained important structures. Lines with noise were
removed from images, and regenerated by using average values
from adjacent lines.
Evaluation of Cell Membrane Integrity and
Esterase Activity Using Flow Cytometry
We assessed isoeugenol’s effect on membrane permeability and
esterase activity using PI and FDA, respectively. Propidium
iodide is a membrane impermeable dye that binds to nucleic
acids and fluoresce red if the membrane integrity is lost,
indicative of dead cells. Fluorescein diacetate is a lipophilic non-
fluorescent molecule that readily diffuses across membranes,
and within metabolically active cells FDA is hydrolyzed
by unspecific esterases to the polar membrane-impermeant
fluorescent molecule fluorescein.
For E. coli we used a 4× PI work solution (kit L13152)
made according to the manufacturer, while L. innocua cells
were stained with a 1.5mM PI work solution (kit 7012) made
with filter-sterilzed deionized water. The FDA work solution was
prepared at a 5mg/mL concentration in acetone. Stains were
stored at−20◦C in the dark until use.
Cell suspensions were prepared with a cell density of 106
CFU/mL in MES-buffer. Live cells stained with FDA and heat-
killed (85◦C, 30min) cells stained with PI, provided the detection
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boundaries for cells stained with PI or FDA, respectively. Heat-
killed cells and cells treated with a final isoeugenol concentration
of 0, ½× MIC, MIC, and 2× MIC at 5 × 105 CFU/mL in MES-
buffer for an hour at 25◦C were harvested by centrifugation
(5000 × g, 10min). Cell pellets were resuspended in 1mL MES-
buffer, and hereafter mixed with 20µL FDA and incubated at
37◦C for 30min to allow intracellular enzymatic conversion
to fluorescein. Labeled cells were harvested by centrifugation
(5000 × g, 10min), and resuspended in 200µL MES-buffer and
either 66µL 4× PI stain for E. coli or 2µL 1.5mM PI stock for
L. innocua. Propidium iodide stained samples were incubated in
the dark for 15min at room temperature, and then immediately
transferred to flow cytometer for analysis.
A Gallios flow cytometer (Beckman Coulter, Miami, FL, USA)
was used for flow cytometry analysis. All channels were calibrated
with FlowCheck Fluorospheres (Beckman Coulter, Miami, FL,
USA) prior to sample analysis. Fluorescein and PI were excited
using the 488 nm laser line. Green fluorescence signal from
fluorescein stained cells were collected in the FL1 channel
(525/50), whereas PI signal was detected using FL2 (575/26 nm)
and FL3 (620/30 nm) channels. Cell density in each sample was
adjusted with MES-buffer so signal from 50 to 1000 cells/s was
detected under constant flow rate. Samples and controls were all
made in triplicate, and at least 30,000 events were collected for
each replica.
Flow cytometry data analysis was performed using Kaluza
software (version 1.2). Bacterial populations were gated based
on their scattering in forward and side direction to minimize
noise. Gated populations were analyzed in dual-parameter
contour plots of red and green fluorescence signal intensities
to differentiate bacterial populations based on their fluorescence
properties. The position of a quadrant dividing negative and
positive fluorescence signal histograms were chosen for each
fluorophore based on the position of a fluorescence-minus-
one control population in the contour plot. Which means that
dead cells stained with PI worked as the negative fluorescence
signal for fluorescein, and vice versa. Statistical significance
of isoeugenol’s effect on cell membrane integrity and esterase
enzyme activity was assessed using One-Way ANOVA test (p <
0.05) to compare means of several groups using Minitab R© 16.2.4
(Minitab inc., State College, Pennsylvania).
Evaluation of Membrane Permeablization by
Calcein-leakage Assay
We assessed isoeugenol’s membrane permeabilization efficacy
using calcein encapsulated large unilamellar vesicles (LUVs)
with an E. coli lipid composition representing the cytoplasmic
membrane of Gram-negative bacteria.
Calcein encapsulated LUVs were prepared by evaporating the
organic solvent from E. coli polar lipid extract in a glass vial under
nitrogen gas until a dry lipid film appeared. Removal of residual
organic solvent was done by having the lipid film under vacuum
in a dessicator for 2 h. Vacuum was liberated and nitrogen was
applied to the glass vial. We hydrated the dry lipid film with
MES-buffer containing 70mM calcein to a lipid concentration
of 10mg/mL, and dissolved the lipid film by shaking at 200 rpm
and 37◦C overnight. The resulting multilamellar vesicle lipid
solution was alternated eight times between liquid nitrogen and a
40◦C waterbath to form unilamellar vesicles. The vesicles were
extruded 24 times through a 19mm Nucleopore Track-Etched
membrane with a pore size of 100 nm (Whatman, Clifton, NJ,
USA) using a MiniExtruder with a heating block (Avanti Polar
Lipids Inc., Alabaster, Al, USA) equilibrated at 37◦C. We loaded
500µL of the calcein-loaded LUVs on a PD-10 desalting column
(GE Healthcare, Buckinghamshire, UK) previously equilibrated
in MES-buffer, collected the eluated calcein-LUV fraction, and
diluted it to a final lipid concentration of 58.5µM.
Calcein-leakage induced by isoeugenol was monitored using
a Tecan GENios Pro microtiter plate reader (Tecan Group,
Männedorf, Switzerland) and 96-well black NUNC optical-
bottom microtiter plates (No. 265301, Thermo Scientific,
Rochester, NY, USA). We added 200µL of calcein-LUV solution
to all wells and measured the calcein fluorescence baseline (F0)
at 37◦C by exciting calcein at 448 nm and detecting emission at
485 nm. Isoeugenol was added in wells to a final concentration
range between 0.00002 and 2mg/mL in duplicate. Wells with
untreated calcein-LUVs were included as control. The microtiter
plate was incubated at 37◦C for an hour before measuring the
calcein fluorescence signal (F). Five microliters of 1% Triton™
X-100 solution was added to all wells to fully permeabilize all
vesicles and the calcein signal was measured again (Fmax). The
microtiter plate was sealed in between individual measurements
to prevent evaporation, and all measurements were conducted
until a stable baseline was achieved. The relative amount of
released calcein was averaged and calculated as:
Calcein release (%) =
F − F0
Fmax − F0
×100%
Baseline was subtracted from all data points using an average
value of a linear section of the graph.
Confocal Laser Scanning Microscopy of Giant
Unilamellar Vesicles Treated with Isoeugenol
We wanted to visualize how isoeugenol affected membranes and
therefore used confocal laser scanning microscopy to monitor
the interaction between giant unilamellar vesicles (GUVs) and
isoeugenol in solution.
We prepared the GUV solution using a home-build
electroformation chamber as previously described by Vad et al.
(2010). A 10mg/mL DOPG:DOPC (20:80) lipid solution were
prepared in chloroform. A 15µL aliquot of the lipid solution
was placed on each of the two platinum electrodes in the
electroformation chamber. Chloroformwas removed by applying
nitrogen gas to the electroformation chamber followed by
incubation at 95◦C for 5min, and subsequently filled with
800µL of a 200mM sucrose solution containing Alexa Fluor
488 and Alexa Fluor 633 hydrazide in a 1:1 ratio. We connected
the platinum electrodes with a function generator (Digimess
FG100, Grundig Instruments, Nürnberg, Germany) and applied
an alternating current (10Hz, 1.5V, sinusoidal wave function)
for 90min while keeping the chamber in the dark and at room
temperature in order to form GUVs. The GUVs were gently
detached from the electrodes by mixing the solution in the
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chamber with a pipette. Vesicles and free stain in solution were
separated by running the GUV solution over a PD-10 desalting
column pre-equilibrated with 200mM glucose solution. The
eluted solution containing GUVs were collected in an eight-
chambered borosilicate coverglass (No. 155411, Lab-Tek, Nunc)
and diluted in 200mM glucose to a final volume of 300µL. Giant
unilamellar vesicles were allowed to sediment to the bottom of
the coverglass by incubating it overnight at 4◦C.
The interaction between isoeugenol and GUVs were observed
in solution using a LSM 700 confocal laser scanning microscope
from Zeiss (Göttingen, Germany). Laser line 488 and 639 nm
were used to excite Alexa488 and Alexa633, while emission were
detected after passing a dichroich beam splitter set at 629 nm and
either a SP 640 filter and LP 640 filter, respectively. Triplicate
time-series of images of the same field of view were taken
sequentially every 4 s using a Plan-Apochromat 40×/1.3 oil
immersion objective. Images were recorded using a pixel dwell
of 0.79µs, an image size of 1024 lines per frame, and two times
averaging of each line. Prior to recording we added 5µL of
10mg/mL isoeugenol solution prepared in 5mM MES-buffer
outside the field of view, and the imaging started approximately
5min after injection. Usually no interactions were observed
the first 10–15min after injection due to the slow diffusion of
molecules within the viscous glucose solution. The arrival of
isoeugenol into the field of view was indicated by increased
fluctuation of vesicles and changes in direction of solution flow.
Time-series of images were analyzed in the blue edition of
Zen lite 2012 (version 1.1.2.0, Carl Zeiss Microscopy GmbH,
Germany).
Evaluation of Isoeugenol’s Effect on Supported
Lipid Bilayer Topography Using AFM
Membrane active compounds might induce changes in the
integrity and lipid phases of membranes, and therefore
AFM has been a valuable tool to investigate the interplay
between antimicrobials and supported membranes in numerous
studies (Shaw et al., 2006; Yu et al., 2009; Hyldgaard et al.,
2012b; Balhara et al., 2013). Using this technique we could
visualize the initial effect of isoeugenol on models of bacterial
membranes.
Supported lipid bilayers (SLBs) were prepared from E.
coli polar lipid vesicles prepared as in the calcein-leakage
assay without calcein and with a sonication step instead of
extrusion through a pore-membrane. After the freeze-thaw cycle,
we prepared a small unilamellar vesicle solution (SUV) by
sonicating the lipid solution using a rod sonicator (70W, 50%
of maximal power, 3-mm probe diameter, Sonopuls ultrasonic
homogenizers, Bandelin Electronic, Berlin, Germany) for 5min
while submerged in an ice bath.
The SUV solution was added to freshly cleaved mica squares
glued to 18-mm circular coverslip in a temperature controlled
JPK Biocell holder (JPK Instruments, Berlin, Germany) and
mixed with MES-buffer containing CaCl2 to final concentrations
of 0.3mg lipid/mL and 20mMCa2+. The solution was incubated
20min at 37◦C in order to allow the SUVs to bind to the substrate
and form a SLB. The SLB was washed at least three times with
CaCl2-free MES-buffer and suspended in CaCl2-free MES-buffer
at 37◦C. Contact mode imaging of SLBs was performed using
CSC38/noAl Si3N4 cantilevers fromMikromash (Tallin, Estonia)
with a spring constant of 0.03 to 0.09N/m. Images of SLBs were
acquired of the untreated membrane, and again after 60min
treatment at 37◦C with isoeugenol at final concentrations of
0.008mg/mL or 0.03mg/mL. The bilayer was rinsed with CaCl2-
free MES-buffer five times before recording images of the treated
SLB. At least three random 5 × 5µm areas of each of triplicate
samples were recorded. AFM Images were acquired as 512× 512
pixel images at a scan rate of 0.5Hz using a setpoint below
250 pN.
Assessing Isoeugenol’s Effect on Membrane
Fluidity by Fluorescence Anisotropy
Interaction between isoeugenol and membranes could affect
membrane fluidity, and therefore we measured changes in
anisotropy of the fluorescent probe DPHwhen situated inside the
hydrophobic core of LUVs made of E. coli polar lipid or a 20:80
composition of DOPG:DOPC. The DPH probe inserts in the
bilayer core, and its depolarization property is then influenced
by the packing of the acyl chains (Trevors, 2003).
The DPH powder was dissolved in acetone to a final
concentration of 100µM and added to the chloroform solution
containing E. coli polar lipid extract or DOPG:DOPC (20:80)
at a molar concentration of 1:300 (DPH:lipid). The LUVs were
prepared as for the calcein encapsulated LUVs, except addition of
calcein and running the LUV suspension over a PD-10 desalting
column. The final lipid concentration was adjusted to 56µM
using 5mM MES-buffer at pH 6.0. Large unilamellar vesicles of
E. coli polar lipid extract and DOPG:DOPC were mixed with
isoeugenol to a final concentration between 0.008 to 0.03mg/mL
and 0.002 to 0.15mg/mL, respectively. Samples were incubated in
the dark for 5min at 37◦C for E. coli polar lipid LUVs, and 25◦C
for DOPG:DOPC LUVs.
Fluorescence determinations were performed with a LS55
fluorospectrometer (Perkin-Elmer, Waltham, USA) with
excitation at 360 nm and emission detection at 430 nm with
a 10 nm bandwidth. Anisotropy values representing the
dynamics of acyl lipid chains were determined by measuring
the polarization ratio of emitted light parallel (IVV) and
perpendicular (IVH) to a vertical excitation polarizer.
Anisotropy values (r) were determined as:
r =
(IVV − G · IVH)
(IVV + 2 · G · IVH)
The grating factor is an intrinsic correction factor for polarization
calculated as:
G =
IHV
IHH
All DPH fluorescence determinations were performed in
triplicate for E. coli polar lipid, and in duplicate for DOPG:DOPC
LUVs. Each replicate was measured between three and ten times
with an integration time of 5 s.
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Assessing Binding and Interaction with
Supported Lipid Bilayers Using Quartz Crystal
Microbalance with Dissipation Monitoring
We hypothesized that isoeugenol interacted with the lipid
bilayer to cause changes in membrane stability and fluidity,
thus we monitored changes in membrane mass and viscoelastic
properties upon exposure to isoeugenol. The quartz crystal
microbalance with dissipation (QCM-D) monitors changes in
resonance frequency (1f ) and energy dissipation (1D) of an
oscillating quartz crystal, which indicates changes in mass and
viscoelastic properties of the membrane, respectively.
QCM-D measurements of membranes were performed using
the Q-sense E4 system (Q-sense AB, Västra Frölunda, Sweden)
thermostated at 37◦C, and 5MHz sensor crystals with 50 nm
Silicon dioxide coating (Q-sense Sensor QSX 303 SiO2,Q-sense
AB, Västra Frölunda, Sweden city, country). Sensor crystals
were stored in 2% SDS, washed with Milli-Q water, dried in
a stream of N2 gas, and subjected to UV-ozone treatment for
20min, washed with Milli-Q water, dried with N2 gas, followed
by a final UV-ozone treatment for 20min. The crystals were
then rinsed with Milli-Q water and dried with N2 prior to
placing them in the QCM-D mounting chambers. Changes in
resonance frequency and dissipation were measured using Q-soft
software (version 3.1.25.604) on four channels at the 3rd, 5th,
7th, 9th, 11th, and 13th overtones of the fundamental resonance
frequency.
We prepared a 10mg/mL DOPG:DOPC (20:80) SUV lipid
solution following same procedure as for E. coli SUVs described
in section Evaluation of Isoeugenol’s Effect on Supported Lipid
Bilayer Topography using AFM, except the thaw-freeze cycle
and the rod sonicator power was set to 20%. Sensor crystals
were equilibrated in 5mM MES-buffer (pH 6.0), and SLBs were
formed by first introducing 0.6mg/mL DOPG:DOPC SUVs in
MES-buffer at a flow rate of 0.1mL/min for approximately 3min,
followed by 5mM MES-buffer with 20mM CaCl2 at a flow
rate of 0.1mL/min using an Ismatec IPC-N 4 peristaltic pump
(Ismatec SA, Glattburg, Switzerland). Excess lipid was removed
from the SLBs by flushing with CaCl2-free 5mM MES-buffer
injected at 0.1mL/min, and the system was finally equilibrated
in the same buffer without flow. Isoeugenol dissolved in 5mM
MES-buffer was then injected at either 0.008 or 0.03mg/mL
at 0.1mL/min until complete exchange of chamber content,
after which the flow was stopped for 60min. Subsequent
washing was performed with 5mM MES-buffer at 0.1mL/min
prior to stopping the flow to evaluate the reversibility of the
interaction.
Data modeling was carried out in Q-tools (version 3.1.25.604,
Q-sense AB, Västra Frölunda, Sweden) on 11 raw data sets of
DOPG:DOPC membranes to evaluate SLB area mass using the
one-layer Voigt viscoelastic model in comparison to Sauerbrey
model on frequency and dissipation data from the 9th, 11th, and
13th harmonics. We used fixed parameters for the fluid density
(1000 kg/m3), the fluid viscosity (0.001 kg/ms), and the layer
density (1000 kg/m3). And fitted the layer parameters within
following boundaries: viscosity (0.0005–0.01 kg/ms), shear (500
to 1× 109 Pa), and thickness (1× 10−10 to 1× 10−6m).
Results
Antimicrobial Activity of Isoeugenol
We assessed the influence of isoeugenol at different
concentrations on growth and cell viability of E. coli and L.
innocua cells using turbidity measurements and plate spreading,
respectively.
Isoeugenol inhibited growth of E. coli cells at 0.6mg/mL and
L. innocua cells at 1 mg/mL, indicating their respective MIC
values. Microorganisms treated with isoeugenol at ½× MIC
had a decreased growth rate and decreased maximum growth
(Figure 2). Isoeugenol at MIC or 2×MIC initially decreased cell
viability, but after 16 h of treatment, E. coli cells treated at MIC
regained growth, suggesting that isoeugenol exhibit a reversible
inhibitory activity against E. coli cells (Figure 2A). Interestingly,
isoeugenol had an initial bactericidal activity against L. innocua
that declined in rate after an hour at MIC, whereas 2×MIC killed
FIGURE 2 | Time-kill curves of isoeugenol’s effect on E. coli (A)
and L. innocua (B) cell viability. Cells were treated with isoeugenol
at 0 (black circles), ½× MIC (gray triangle), MIC (dark gray square), or
2× MIC (white diamond) in TSB (pH 6.0) at 25◦C. Dashed line
indicates detection limit (50CFU/mL). Error bars are standard deviation
(SD) of triplicates.
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L. innocua cells to undetectable levels (Figure 2B). Based on the
time-kill curves, we chose to use 1 h of isoeugenol treatment of
bacteria for the remainder of the experiments.
Isoeugenol Does Not Affect Cell Morphology
After confirming isoeugenol’s antimicrobial activity against E.
coli and L. innocuawe used AFM to visualize if isoeugenol caused
changes in cell morphology. AFM images did not reveal any
effect of isoeugenol on cell morphology of neither E. coli nor
L. innocua (Figure 3). No apparent difference in cell length or
width other than natural variation of cells in the exponential
growth phase existed. Phase images revealed no changes in tip-
sample interactions between treated and untreated cells (data not
shown).
Isoeugenol Affects Membrane Integrity and
Possibly also Enzyme Activity
Based on the cell morphology results we decided to investigate
isoeugenol’s effect on cell membrane integrity and intracellular
esterase activity using flow cytometry. Isoeugenol compromised
the cell membrane of E. coli and L. innocua cells, which at the
same time caused inactivation of intracellular esterase activity
(Figure 4).
Isoeugenol affected membrane permeability for E. coli cells
as indicated by PI staining, and the fraction of cells with
damaged membrane increased as the isoeugenol concentration
increased from ½× MIC to MIC. Surprisingly, increasing the
concentration further to 2×MIC led to a decrease in the number
of E. coli cells with a damaged membrane (Figure 4A). Lack of
FIGURE 3 | Atomic force microscopy amplitude images of E. coli
(A–D) and L. innocua (E–H) cell morphology after isoeugenol
treatment. Cell morphology was imaged in air after treatment with
isoeugenol at 0 (A,E), ½× MIC (B,F), MIC (C,G), or 2× MIC (D,H) in
MES-buffer (pH = 6.0) at 25◦C for an hour. Images of E. coli and L. innocua
were 4× 4 and 3× 3µm, respectively.
FIGURE 4 | Isoeugenol induce changes in cytoplasmic membrane
integrity (A) and esterase activity (B) of E. coli (black bars)
and L. innocua (gray bars) cells. Living and heat treated cells
suspended in MES-buffer (pH 6.0) were treated with or without
isoeugenol at different concentrations for an hour at 25◦C, then
harvested and resuspended in MES-buffer together with FDA,
followed by incubation for 30min at 37◦C. Cells were harvested and
resuspended in MES-buffer before PI staining, except a control with
no-stain. Cells with damaged membranes (A) or inactive esterases
(B) were stained with PI or FDA, respectively. Asterisk indicates no
statistical significant difference from untreated sample. Error bars =
SD (n = 3).
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FDA staining is indicative of inactive esterases and/or loss of
membrane integrity, and this assay only found an effect from
incubation with 2×MIC (Figure 4B). Examination of L. innocua
showed a trend toward an increasing effect with increasing
isoeugenol concentration in both assays, but the effect was not
statistically significant at ½× MIC (Figure 4). These results
indicate that isoeugenol permeabilizes bacterial membranes, and
possibly inactivates enzymes within L. innocua cells prior to
membrane permeabilization.
Isoeugenol Affects Membrane Stability in a
Non-disruptive Manner
The complexity of microorganisms made it difficult to assess
isoeugenol’s interaction with the cytoplasmic membranes, and
therefore we used biophysical investigations with LUVs, GUVs,
and SLBs to better understand the mechanism leading to
membrane permeabilization. We studied isoeugenol’s efficiency
for permeabilizing membranes using calcein-encapsulated LUVs,
and visualized the direct physical interaction between isoeugenol
and membranes following morphology changes of GUVs in
suspension, and topographical changes of SLBs on a substrate.
The efficiency of isoeugenol to permeabilize phospholipid
membranes was investigated using fluorescent dye-encapsulated
LUVs. Isoeugenol permeabilized calcein-encapsulated E. coli
lipid vesicles in a concentration-dependent manner, and required
0.004mg/mL of isoeugenol (10 molecules of isoeugenol per lipid)
to affect membrane permeability, and 0.05mg/mL isoeugenol
(120 molecules of isoeugenol per lipid) for full release (Figure 5).
The use of confocal laser scanning microscopy and
DOPG:DOPCGUVs allowed us to visualize the permeabilization
of isoeugenol in solution at 0.16mg/mL, and we observed
three interesting details: Firstly, isoeugenol initially induced
fluctuation of spherical GUVs without compromising vesicle
integrity (Figure 6 and Supporting Video). GUVs released
intravesicular GUVs during fluctuation, while maintaining
their overall shape and continuity (Figure 6, white arrows,
and Supporting Video). Secondly, transformation processes
changed GUV’s shape into elongated or dumbbell shaped
vesicles, which either divided into smaller GUVs, or in some
cases instantly fused GUV-ends together forming invaginated
sphero-stomatocytes that encapsulated exo-vesicular solution
(Figure 6, yellow arrows, and Supporting Video). Lastly, some
of the fluctuating GUVs formed tubular protrusions, which
transformed into long chains of beads (Figure 6, red arrows,
and Supporting Video). Very few GUVs burst open, but when
they did the remaining lipid formed long chains of lipid beads or
reshaped into new GUVs with beaded protrusions (Supporting
video). When isoeugenol reached the GUVs in the field of
view, most of the interactions happened within a couple of
minutes and continued to affect GUVs for the reminder of
the time-series (Figure 6 and supporting video). Interestingly,
some GUVs contained intravesicular liposomes that started
FIGURE 5 | Increasing concentrations of isoeugenol induce
calcein leakage from large unilamellar vesicles of E. coli polar
lipid extract. Vesicles with encapsulated calcein were suspended in
MES-buffer (pH 6.0) and exposed to increasing concentrations of
isoeugenol, either expressed as concentration (mg/mL, lower axis) or
as a function of isoeugenol to lipid concentration ([IE]/[L], upper axis).
Calcein intensity signal was measured before and after 1 h treatment
at 37◦C, and normalized to the signal obtained at full permeabilization
for individual [IE]/[L] ratios. A lipid concentration of ∼12 nmol was used
for all [IE]/[L] ratios.
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FIGURE 6 | Time-series of DOPG:DOPC (20:80) giant unilamellar
vesicles (GUVs) before and during treatment with isoeugenol.
Confocal laser scanning microscope images were sequentially acquired of
the same field-of-view of GUVs stained with the membrane-bound dye Alexa
488 dextran (green) and the intravesicular water-soluble dye Alexa Fluor 633
hydrazide (red). Untreated GUVs (A) remained stable and intact until
isoeugenol came in contact with GUVs (B). (C–F) At later time-points the
interaction between isoeugenol and GUVs results in four distinct structural
changes of vesicles: Fluctuation of vesicles (not indicated in images), release
of intravesicular GUVs (white arrows), affected GUV shape with diverse
outcomes (yellow arrows), and tubular or bead protrusions from GUVs (red
arrows). Bars correspond to 20µm.
having morphological changes without disintegration of the
outer bilayer, indicative of isoeugenol’s ability to permeabilize
membranes without affecting membrane continuity (Figure 6
and supporting video). These results suggest that isoeugenol
directly affects membrane structure, fluidity, and stability.
In order to visualize the permeabilization mechanism in more
detail, we monitored how isoeugenol affected the topography of
SLBs using AFM. We exposed SLBs to 0.008 or 0.03mg/mL of
isoeugenol, which induced low and high leakage from calcein-
encapsulated vesicles, respectively. Untreated E. coli polar SLBs
topography appeared homogeneous and intact with small height
differences of approximately 0.2 nm (Figure 7A). Low isoeugenol
concentrations induced the appearance of small protrusions
from the SLB with a height ranging between 1 and 2.5 nm
above the SLB (Figure 7B). At high isoeugenol concentration,
the membrane topography became more heterogeneously
distributed, with small membrane indentations and 12 nm large
“bubbles” protruding from the membrane (Figure 7C). This
indicates that isoeugenol affects membrane topography, resulting
in changes in lipid packing and/or formation of transient pores,
which disturbs membrane stability.
Isoeugenol Interacts Reversible with Membranes
Making Bilayers More Viscoelastic
Preceding results indicated that nonionic isoeugenol molecules
could situate in the membrane and change the permeability,
topography, and shape dynamics of membranes. In order
to assess the effect of isoeugenol on membrane fluidity and
viscoelastic properties, we measured fluorescence anisotropy of
DPH-probed LUVs and monitored the real-time interaction
dynamics between isoeugenol and membranes using QCM-D.
Surprisingly, treatment of DPH-probed DOPG:DOPC lipid
vesicles with increasing concentrations of isoeugenol for 5min
indicated an increase in anisotropy values compared to untreated
DPH-vesicles, demonstrating isoeugenol decreased membrane
fluidity at room temperature (Figure 8). DPH-probed E. coli
lipid at 37◦C treated with 0.03mg/mL isoeugenol had increased
DPH fluorescence anisotropy values that exceeded the signal of
untreated DPH-vesicles (p < 0.05) (Figure 8). These results
can be interpreted as isoeugenol increases the acyl chain order
of vesicle lipid bilayers, thus exhibiting a membrane rigidifying
effect.
We evaluated isoeugenol’s effect at 0.008 and 0.03mg/mL on
the mass and viscosity of SLBs consisting of 20:80 DOPG:DOPC
in real-time on silica surfaces using the QCM-D technique.
The QCM-D profiles for all SLBs showed a significant baseline
drift of the frequency, not dissipation, just prior to addition
of the SUVs (Figure 9A), thus the data were only analyzed
semi-quantitatively by comparing trends in frequency shift, 1f,
and dissipation, 1D. The creation of SLBs (n = 11) resulted
in frequency shifts of −20.0 ± 2.4Hz. A concomitant low
dissipation value of 0.26 ± 0.09 × 10−6 indicated formation of a
stable DOPG:DOPC bilayer (Figure 9A). Addition of isoeugenol
at 0.008mg/mL resulted in no noticeable changes. However,
addition of 0.03mg/mL resulted in a drop in frequency after
rinsing, suggesting that isoeugenol binds to membranes and thus
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FIGURE 7 | Contact mode atomic force microscope height images of
E. coli supported lipid bilayers before (A), and after isoeugenol
treatment (B,C). Untreated E. coli lipid (A,D) was imaged in MES-buffer (pH
6.0) at 37◦C, and subsequently treated with either low (B,E) or high (C,F)
concentration isoeugenol as evaluated on calcein leakage (Figure 5) for an
hour and rinsed with fresh MES-buffer before imaging. Cross-sectional
profiles (D–F) taken at the white line in the corresponding height images have
different height scales. Images are 5× 5µm segments, where the bright and
dark areas correspond to higher or lower structures than the mean average
height of the bilayer.
FIGURE 8 | Isoeugenol’s effect on large unilamellar vesicles fluidity.
Fluorescence anisotropy of diphenylhexatriene in vesicles composed of
DOPG:DOPC (20:80) (black circles) or E. coli polar lipid extract (white circles)
were measured as a function of increasing concentrations of isoeugenol in
MES-buffer (pH 6.0) at 25 or 37◦C, respectively. Anisotropy is a measure of
lipid ordering and bilayer fluidity, and an increased fluidity have a decrease in
anisotropy, while low membrane fluidity has increases anisotropy signal.
Mean anisotropy values are shown for duplicates of DOPG:DOPC (20:80)
vesicles, while average values for E. coli vesicles are shown for triplicates.
Error bars = SD (n = 3).
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FIGURE 9 | Isoeugenol binds reversible to SLB and increases
membrane hydration. (A) Representative measurement of frequency (gray
line) and dissipation (black line) changes at the 9th harmonic of a DOPG:DOPC
(20:80) membrane at 37◦C. To form SLBs we introduced lipid vesicles (black
arrow) in MES-buffer (pH 6.0), followed by pure MES-buffer (pH 6.0) with
20mM CaCl2 (dark gray arrow). All rinsing steps was performed with fresh
MES-buffer without CaCl2 (pH 6.0, light gray arrow) to remove excess lipid,
and the flow was stopped momentarily (light gray arrow with asterisk).
Isoeugenol was injected at a final concentration of 0.03mg/mL (hollow arrow)
until chamber content was exchanged, and the flow was stopped (hollow
arrow with asterisk) until treatment had lasted 60min, followed by buffer-rinse
for 45min before the rinsing was stopped (light gray arrow with asterisk).
(B) Modeling of area mass changes during SLB formation and isoeugenol
exposure using Sauerbrey (gray line) and one-layer Voigt (black line).
increasing the mass of the SBL (Figure 9A). The corresponding
dissipation of SLBs increased during and after treatment with
isoeugenol, and the higher dissipation per frequency could
suggest amore hydrated SLB, which is less rigid ormore saturated
with fluid after exposure to isoeugenol (Wang et al., 2011).
Analysing the QCM-D data using the Sauerbrey and Voigt
model, respectively, confirmed that isoeugenol bound to the
SLB as we observed an increase in area mass after exposure to
0.03mg/mL isoeugenol (Figure 9B). Interestingly, the area mass
of the membrane exposed to high concentration of isoeugenol
remained constant during the exposure, and after the final rinse
the mass dropped but remained above the initial SLB, this
suggests that isoeugenol interact with membranes in a reversible
manner (Figure 9B). Collectively, the QCM-D results suggest
that a small fraction of isoeugenol bind to bilayers making it more
viscoelastic (more hydrated).
Discussion
Antimicrobial Activity of Isoeugenol
We assessed isoeugenol’s inhibitory activity and its effect on
cell viability of E. coli and L. innocua. The MIC values for E.
coli were between one and six-fold higher than previous reports
(Zemek et al., 1979; Kang et al., 1992). Isoeugenol’s MIC against
L. innocua was five-fold higher than previously determined for
L. innocua and the closely related Listeria monocytogenes (Faith
et al., 1992; Vitt et al., 2001). The discrepancy between our
and previous studies could be caused by different cultivation
conditions, use of different strains which may show different
susceptibility, or the use of different agents, such as ethanol,
dimethyl sulphoxide, dimethylformamide, or Tween 80, to
disperse isoeugenol in solution (Faith et al., 1992; Kang et al.,
1992; Vitt et al., 2001).
Time-kill curves provided more insight into isoeugenol’s
effect on viability and growth over time. Although growth of
E. coli was initially inhibited and the number of viable cells
even dropped by 1–2 log units when adding isoeugenol at the
MIC concentration, growth resumed after approximately 16 h
of incubation. Analyzing the result from a MIC test after 24 h
incubation resulted in a MIC value of 0.6mg/mL, but if the
culture had been incubated longer we would have measured net
growth at this concentration. This observation underlines the
sensitivity of the MIC assay regarding duration and conditions
of incubation. The regrowth of E. coli could be caused by
the following; (i) isoeugenol is a volatile compound and could
have evaporated, allowing surviving cells to grow when the
concentration fell beneath an inhibitory threshold, (ii) cells
could adapt to isoeugenol by excreting molecules, or modifying
the LPS composition, membrane order, or cell hydrophobicity
(Sikkema et al., 1995), or (iii) isoeugenol could be inactivated
by immobilization or conversion to less active compound,
such as vanillin or vanillic acid, as seen in Bacillus spp., and
Pseudomonas spp. cultures (Shimoni et al., 2000; Furukawa et al.,
2003; Kaur and Chakraborty, 2013). Future studies using gas
chromatography measurements could be used to conclude which
scenario causes regrowth of E. coli.
Isoeugenol Destabilizes and Permeabilizes
Membranes
Visual investigation by AFM indicated that isoeugenol had
cytoplasmic or intracellular targets because cells underwent no
morphological changes to the outer membrane or cell wall
(Figure 3). Furthermore, E. coli and L. innocua cells were
fluorescently stained by PI but not FDA, which confirms
that the cytoplasmic membrane was damaged and suggests
that enzyme activity may also be affected (Figure 4) (Schenk
et al., 2011). We observed a discrepancy in our data for E.
coli exposed to isoeugenol at 2× MIC. PI staining showed
permeabilization of all cells at 1× MIC, and it is therefore
counterintuitive that the percentage of PI positive E. coli
decreased when further increasing the isoeugenol concentration
to 2× MIC as we detected no viable cells at this concentration
(Figures 2A, 4A). Furthermore, the results from PI- and FDA-
staining of E. coli at 2× MIC did not agree. PI staining
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indicated permeabilization of approximately half of the cells,
while >90% were FDA-negative. We observed the same
disagreement between PI and FDA staining of L. innocua at
1× MIC. It was previously suggested that phenylpropenes such
as eugenol, cinnamaldehyde, and vanillin could interact with
both membranes and intracellular proteins, thus it is possible
that isoeugenol has two targets and inhibited enzyme activity
in a larger fraction of cells than those with permeabilized
membranes (Fitzgerald et al., 2004; Gill and Holley, 2006a; Di
Pasqua et al., 2007; Domadia et al., 2007; Hyldgaard et al.,
2012a).
In the following, we argue that isoeugenol situate in
membranes and contrary to results from the membrane fluidity
experiment with DPH, isoeugenol has a fluidifying effect
on the cytoplasmic membrane. Our results demonstrate that
isoeugenol interacts with and situates in membranes, evidenced
as an increased mass and changed topography of SLBs, which
consequently destabilize and become permeable (Figures 5,
7, 9B). Isoeugenol’s interaction with membranes could cause
changes in membrane topography because of sequestering of
lipids with preferences for different curvature or acyl chain
lengths (Mrówczyn´ska et al., 2011; Lichtenberg et al., 2013).
Isoeugenol is nonionic so it would not sequester lipids based
on different headgroup charges as it requires cationic charged
molecules to cluster anionic lipids from zwitterionic ones (Epand
et al., 2010). Although we detected decreased membrane fluidity
of DPH-probed LUVs, we propose that isoeugenol increases
membrane fluidity based on more hydrated bilayers observed by
QCM-D upon isoeugenol exposure (Figure 9A). Furthermore,
we observed that isoeugenol induced structural changes to GUVs
in the form of fluctuations, tubular and bead protrusions, release
of intravesicular GUVs and formation of sphero-stomatocytes,
which previous studies attributed to increased membrane fluidity
in the case of stilbenes, octaethyleneglycol dodecylether, and
amyloid beta peptides in the presence of oxysterols (Mavcic
et al., 2004; Morita et al., 2010; Phan et al., 2013) (Figure 6 and
Supporting Video). Structural changes of GUVs in the presence
of isoeugenol therefore contradicts structural changes of GUVs
exposed to rigidifying molecules like flavonoids, which cause
aggregation, endo-budding, and bursting with subsequent release
of daughter vesicles or release of small lumps (Phan et al.,
2014). Fluctuations (or quakes) of GUVs are an effect of changes
in area-to-volume ratio due to insertion of molecules into
membranes, and might cause transient holes in the membrane
without affecting GUV shape and continuity, which could
explain the leakiness of vesicles and cells when exposed to
isoeugenol (Nomura et al., 2001; Hamada et al., 2012). Formation
of tubular and bead protrusions relieve this excess area of
GUVs, whereas sphero-stomatocytes have been proposed to arise
when foreign molecules penetrate deeply into the bilayer thus
promoting large positive and negative curvature changes in
both membrane leaflets (Phan et al., 2013, 2014). In addition
to GUVs, QCM-D measurements confirmed that membranes
became more hydrated when isoeugenol incorporated into lipid
bilayers (Figure 9A). Isoeugenol’s ability to induce structural
changes in membranes, like tubular or bead structures, might
be more pronounced for LUVs than GUVs and SLBs because
of lipid-packing defects caused by increased curvature, which
enhances the accessibility of isoeugenol to exposed hydrophobic
areas in curved membranes (Huang and Ramamurthi, 2010). It
was previously demonstrated that cholesterol induce formation
of similar GUV shape changes where “beads” contain ordered
lipid, while the nodes contain disordered lipid (Yanagisawa et al.,
2010). Hence, we speculate that the decreased membrane fluidity
measured for LUVs could be an artifact caused by formation
of tubular or bead structures (Figure 6). In our case the bead-
like structures might restrict the movement of DPH within the
hydrophobic region of vesicles, while fluid membrane will situate
at nodes in-between beads (Yanagisawa et al., 2010). This can
explain the contradiction between DPH results, and QCM-D and
GUV results.
Isoeugenol’s Mode of Action Resembles a
Non-disruptive Detergent-like Mechanism
In this section we hypothesize that isoeugenol’s mechanism of
action on cytoplasmic membranes resembles a non-disruptive
detergent-like mechanism. Isoeugenol is a small nonionic
molecule with an aromatic ring and a hydroxyl-group, which
has a structural resemblance to e.g., the aromatic amino acid
tyrosine or perillaldehyde, both having the ability to localize
at the lipid headgroup region and thus affect packing of lipids
(Sanderson and Whelan, 2004; Sanderson, 2005; Witzke et al.,
2010). Based on molecular dynamic simulations of structurally
related compounds, we propose that isoeugenol form H-bonds
between the polar side chains and phosphate or carbonyl groups
on phospholipid headgroups, and position around 1 nm from
the center of the bilayer with the propenyl-chain intercalating
into the acyl chains to destabilize membranes (Sanderson and
Whelan, 2004;Witzke et al., 2010; Lomize et al., 2011). Isoeugenol
would thus take up space in the head group region of the
outer leaflet of membranes, increase membrane fluidity, and
enhance the interfacial lateral pressure of the outer leaflet
of the membrane, which in turn affects lipid packing and
destabilize membranes to become leaky and induce shape
changes.
Molecular dynamics simulations have shown that essential
oil constituents like perillaldehyde or perillyl alcohol carrying
more hydrophilic groups require more energy to traverse the
membrane and have a 700-fold slower flip-flop rate than the
nonpolar constituent limonene (Witzke et al., 2010). The low flip-
flop rate could make it difficult for the essential oil constituents
to diffuse across membranes and interact with intracellular
targets without permeabilizing the membrane. In accordance
with structural changes of GUVs, isoeugenol’s destabilizing effect
resembles a detergent-like mechanism for slow flip-flop rate
sodium dodecyl sulfate or slow addition of the nonionic detergent
octaethyleneglycol dodecylether, however isoeugenol differed
from these detergents by not causing liposomal shrinkage or
vesicle bursting (Mavcic et al., 2004; Sudbrack et al., 2010;
Lichtenberg et al., 2013) (Figure 7 and Supporting Video
1). Furthermore, isoeugenol molecules might interact with
membrane-bound proteins like ATPase in a similar manner as
observed for eugenol (Gill and Holley, 2006b), thus affecting a
cell’s ability to maintain homeostasis.
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In conclusion, we propose that isoeugenol interacts reversibly
with E. coli membranes through a non-disruptive detergent-
like mechanism that destabilizes membranes to become leaky.
Because of isoeugenol’s hydrophobic nature, it has tendency to
interact with both neutral and charged membranes, which is also
indicative for its broad antimicrobial range as it inhibits both
yeast and bacteria (Kang et al., 1992). Differences in susceptibility
of various microorganisms could be caused by different
efficiencies of eﬄux pump systems (Nikaido, 1996). Future
studies could focus on investigating isoeugenol’s intracellular
effect on different proteins and enzymes as the structural isomer,
eugenol, has been shown to inhibit a myriad of different
enzymes such as ATPase, histidine decarboxylase, amylase, and
protease (Thoroski et al., 1989; Wendakoon and Morihiko,
1995; Gill and Holley, 2006b). Detailed knowledge about how
isoeugenol gains entry to the cytoplasmic membrane in Gram-
negative bacteria could be obtained by studying isoeugenol’s
interaction with LPS and porins. The cytoplasmic membrane
of Gram-negative bacteria mainly consists of zwitterionic
phospholipids; 5–20% CL, 5–21% PG, and 60–80% PE, while the
majority of phospholipids in Gram-positive bacteria are anionic
phospholipids; 15–50%CL, 40–70%PG, and 0–40 PE (Epand and
Epand, 2011), or special phospholipids like lysyl-PG and lysyl-CL
found in L. innocua (Fischer and Leopold, 1999). Thus, we
suggest investigating how isoeugenol interacts with cytoplasmic
membranes of different composition, acyl chain lengths, or
membrane curvature to further understand how isoeugenol affect
the membrane of L. innocua (Hatzakis et al., 2009; Tomita et al.,
2011). This knowledge could contribute to a better understanding
of the biological differences that lead to variable susceptibility.
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